Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Wan-shan Chen is Director at Belite Bio. OQRO lists 4 transactions filed with the SEC under this name, the latest on Oct 31, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
As of the latest filing on , Wan-shan Chen reported holding 37,259 shares of Belite Bio (BLTE), worth about $6.12M at the last close of $164 (Nov 13, 2026). In the last 12 months, Wan-shan Chen sold $198K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Belite Bio BLTE | 37,259 | 37K direct | $164 | $6.12M | Sep 24, 2026 |
Is this Wan-shan Chen’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Belite BioBLTE
4 disclosures · Apr 2026 – Oct 2026 · 1 sold
Sep 24, 202614Kdisclosed Oct 31
DetailsOfficial recordSep 24, 202614Kdisclosed Oct 31
DetailsOfficial recordApr 9, 2026Sold~$198Kdisclosed Apr 14
DetailsOfficial recordMar 31, 202614Kdisclosed Apr 3
DetailsOfficial recordOn the latest SEC Form 4, dated Sep 24, 2026, Wan-shan Chen reported holding 37,259 shares of Belite Bio (BLTE). At the last close of $164 on Nov 13, 2026, that is about $6.12M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Wan-shan Chen reported 1 open-market sale worth $198K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Wan-shan Chen has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Belite Bio (BLTE), from 2026 to 2026: 0 purchases and 1 sale.
Wan-shan Chen reported 0 open-market purchases and 1 sale here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Wan-shan Chen has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Wan-shan Chen reported 0 open-market purchases and 1 sale since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $198K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.